Recruiting

Neuroelectrophysiology

Sponsor:

Xiangya Hospital of Central South University

Code:

NCT04363658

Conditions

Hydrocephalus

Eligibility Criteria

Sex: All

Age: 16 - 70

Healthy Volunteers: Not accepted

Study Details

Brief summary:

The symptoms of hydrocephalus containing consciousness condition with muscle tone in some patients will be relieved, after the cerebrospinal fluid release test is carried out. Neuroelectrophysiology in patients with disorders of consciousness of post-traumatic hydrocephalus (PTH) can establish the association with consciousness and muscle tone to a certain extent, and predict the shunt effect of PTH with disorders of consciousness.

Conditions

Hydrocephalus

Study ID

NCT04363658

Start date

May 10, 2020

Status verified date

May, 2020

Completion date

Dec 31, 2022

Anticipated

Primary completion date

Dec 31, 2022

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 16 - 70

Healthy Volunteers: Not accepted

Inclusion Criteria:

Patients with disorder of consciousness in traumatic brain injury. The presence of hydrocephalus through image examination.

Exclusion Criteria:

Patients who cannot tolerate shunt surgery. Sedation maintained by greater than 0.15mg/kg/hour of midazolam or the infusion dose of propofol higher than 4mg/kg/hour.

Patients who are participating in drug research or other clinical trials.

Study Design

Enrollment

65 participants

Anticipated

Interventions and Outcome Measures

Primary outcome measure

  • Score of glasgow outcome scale in 6 months after shunt operation [ Time Frame: 6 months ]

Central Contacts and Locations

Central contacts

Locations

Nicolet EEG

Recruiting

Pleasanton, California, United States, 94566

Contacts

More Information

Sponsor

Xiangya Hospital of Central South University

Last update posted

May 19, 2020

Last verified

May, 2020

Keywords

  • neuroelectrophysiology
  • hydrocephalus
  • disorder of consciousness

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Xiangya Hospital of Central South University on 2020-05-19.